Srinivas G Kasi1, S Shivananda2, Sanjay Marathe3, Kripasindhu Chatterjee4, Sunil Agarwalla5, Shashi Kant Dhir6, Sanjay Verma7, Abhay K Shah8, Sanjay Srirampur9, Srinivas Kalyani10, Harish Kumar Pemde11, S Balasubramanian12, Bakul J Parekh13, G V Basavaraja14, Piyush Gupta15. 1. Kasi Clinic, Jayanagar, Bengaluru, Karnataka, India. Correspondence to: Srinivas G Kasi, Convener, ACVIP, Kasi Clinic, 2nd Cross, 3rd Block, Jayanagar, Bengaluru 560011, Karnataka, India. sgkasi@gmail.com. 2. Fortis Hospital, Banneraghatta Road, Bengaluru, Karnataka, India. 3. Marathe Child Care Hospital, Nagpur, India. 4. Department of Pediatrics, Gouri Devi Institute of Medical Science and Hospital, Durgapur, Paschim Bardhaman, West Bengal, India. 5. Department of Pediatrics, MKCG MCH, Berhampur, Odisha, India. 6. Department of Pediatrics, Guru Gobind Singh Medical College, Faridkot, Punjab, India. 7. Division of Infectious Diseases, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India. 8. Dr Abhay K Shah Children Hospital, Ahmedabad, Gujarat, India. 9. Department of Pediatrics, Aditya Super speciality Hospital, Hyderabad, Telangana, India. 10. Department of Pediatrics, Niloufer Hospital, Osmania medical College, Hyderabad, India. 11. Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India. 12. Department of Pediatrics, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, India. 13. Bakul Parekh Hospital for Children, Mumbai, India. 14. Department of Pediatrics, IGICH, Bengaluru, Karnataka, India. 15. Department of Pediatrics, University College of Medical Sciences, New Delhi; India.
Abstract
JUSTIFICATION: In view of new developments in vaccinology and the availability of new vaccines, there is a need to revise/review the existing immunization recommendations. PROCESS: Advisory Committee on Vaccines and Immunization Practices (ACVIP) of Indian Academy of Pediatrics (IAP) had a physical meeting in March, 2020 followed by online meetings (September-October, 2020), to discuss the updates and new recommendations. Opinion of each member was sought on the various recommendations and updates, following which an evidence-based consensus was reached. OBJECTIVES: To review and revise the IAP recommendations for 2020-21 and issue recommendations on existing and new vaccines. RECOMMENDATIONS: The major changes include recommendation of a booster dose of injectable polio vaccine (IPV) at 4-6 years for children who have received the initial IPV doses as per the ACVIP/IAP schedule, re-emphasis on the importance of IPV in the primary immunization schedule, preferred timing of second dose of varicella vaccine at 3-6 months after the first dose, and uniform dosing recommendation of 0.5 mL (15 µg HA) for inactivated influenza vaccines.
JUSTIFICATION: In view of new developments in vaccinology and the availability of new vaccines, there is a need to revise/review the existing immunization recommendations. PROCESS: Advisory Committee on Vaccines and Immunization Practices (ACVIP) of Indian Academy of Pediatrics (IAP) had a physical meeting in March, 2020 followed by online meetings (September-October, 2020), to discuss the updates and new recommendations. Opinion of each member was sought on the various recommendations and updates, following which an evidence-based consensus was reached. OBJECTIVES: To review and revise the IAP recommendations for 2020-21 and issue recommendations on existing and new vaccines. RECOMMENDATIONS: The major changes include recommendation of a booster dose of injectable polio vaccine (IPV) at 4-6 years for children who have received the initial IPV doses as per the ACVIP/IAP schedule, re-emphasis on the importance of IPV in the primary immunization schedule, preferred timing of second dose of varicella vaccine at 3-6 months after the first dose, and uniform dosing recommendation of 0.5 mL (15 µg HA) for inactivated influenza vaccines.
Authors: Steven Black; Uwe Nicolay; Timo Vesikari; Markus Knuf; Giuseppe Del Giudice; Giovanni Della Cioppa; Theodore Tsai; Ralf Clemens; Rino Rappuoli Journal: Pediatr Infect Dis J Date: 2011-12 Impact factor: 2.129
Authors: Emmanuel B Walter; Shilpa Rajagopal; Yuwei Zhu; Kathleen M Neuzil; Mary P Fairchok; Janet A Englund Journal: Vaccine Date: 2010-05-04 Impact factor: 3.641
Authors: Changqing Ma; Jason Y Park; Elizabeth A Montgomery; Christina A Arnold; Oliver G McDonald; Ta-Chiang Liu; Safia N Salaria; Berkeley N Limketkai; Kevin M McGrath; Tina Musahl; Aatur D Singhi Journal: Am J Surg Pathol Date: 2015-06 Impact factor: 6.394
Authors: T John; M Voysey; L M Yu; N McCarthy; M Baudin; P Richard; A Fiquet; N Kitchin; A J Pollard Journal: Vaccine Date: 2015-07-10 Impact factor: 3.641
Authors: B Watson; E Rothstein; H Bernstein; A Arbeter; A Arvin; S Chartrand; D Clements; M L Kumar; K Reisinger; M Blatter Journal: J Infect Dis Date: 1995-07 Impact factor: 5.226
Authors: Carine Claeys; Khalequ Zaman; Ghassan Dbaibo; Ping Li; Allen Izu; Pope Kosalaraksa; Luis Rivera; Beatriz Acosta; Maria Luisa Arroba Basanta; Asma Aziz; Miguel Angel Cabanero; Vijayalakshmi Chandrashekaran; Bartholomew Corsaro; Luis Cousin; Adolfo Diaz; Javier Diez-Domingo; Ener Cagri Dinleyici; Saul N Faust; Damien Friel; Jose Garcia-Sicilia; Grace D Gomez-Go; Maria Liza Antoinette Gonzales; Stephen M Hughes; Teresa Jackowska; Shashi Kant; Marilla Lucero; Ludovic Malvaux; Josep Mares Bermudez; Federico Martinon-Torres; Mariano Miranda; May Montellano; Maria Amor Peix Sambola; Roman Prymula; Thanyawee Puthanakit; Renata Ruzkova; Iwona Sadowska-Krawczenko; Ignacio Salamanca de la Cueva; Etienne Sokal; Jyoti Soni; Henryk Szymanski; Angels Ulied; Anne Schuind; Varsha K Jain; Bruce L Innis Journal: Lancet Child Adolesc Health Date: 2018-03-05
Authors: Varsha K Jain; Joseph B Domachowske; Long Wang; Opokua Ofori-Anyinam; Miguel A Rodríguez-Weber; Michael L Leonardi; Nicola P Klein; Gary Schlichter; Robert Jeanfreau; Byron L Haney; Laurence Chu; Jo-Ann S Harris; Kwabena O Sarpong; Amanda C Micucio; Jyoti Soni; Vijayalakshmi Chandrasekaran; Ping Li; Bruce L Innis Journal: J Pediatric Infect Dis Soc Date: 2017-03-01 Impact factor: 3.164